These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 7936855)

  • 1. The effect of phosphate supplementation on linear growth in children with X-linked hypophosphatemia.
    Seikaly MG; Browne RH; Baum M
    Pediatrics; 1994 Oct; 94(4 Pt 1):478-81. PubMed ID: 7936855
    [TBL] [Abstract][Full Text] [Related]  

  • 2. X-linked hypophosphatemic rickets: a study (with literature review) of linear growth response to calcitriol and phosphate therapy.
    Petersen DJ; Boniface AM; Schranck FW; Rupich RC; Whyte MP
    J Bone Miner Res; 1992 Jun; 7(6):583-97. PubMed ID: 1414477
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nephrocalcinosis is associated with renal tubular acidosis in children with X-linked hypophosphatemia.
    Seikaly M; Browne R; Baum M
    Pediatrics; 1996 Jan; 97(1):91-3. PubMed ID: 8545232
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term influence of calcitriol (1,25-dihydroxyvitamin D) and supplemental phosphate in X-linked hypophosphatemic rickets.
    Chesney RW; Mazess RB; Rose P; Hamstra AJ; DeLuca HF; Breed AL
    Pediatrics; 1983 Apr; 71(4):559-67. PubMed ID: 6300745
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of growth hormone treatment on final height, phosphate metabolism, and bone mineral density in children with X-linked hypophosphatemic rickets.
    Baroncelli GI; Bertelloni S; Ceccarelli C; Saggese G
    J Pediatr; 2001 Feb; 138(2):236-43. PubMed ID: 11174622
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of therapy in X-linked hypophosphatemic rickets.
    Verge CF; Lam A; Simpson JM; Cowell CT; Howard NJ; Silink M
    N Engl J Med; 1991 Dec; 325(26):1843-8. PubMed ID: 1660098
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of treatment on growth and deformity in hypophosphatemic vitamin D-resistant rickets.
    Loeffler RD; Sherman FC
    Clin Orthop Relat Res; 1982; (162):4-10. PubMed ID: 6279346
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renal tubular acidosis associated with vitamin D-resistant rickets. Role of phosphate depletion.
    Minari M; Castellani A; Garella S
    Miner Electrolyte Metab; 1984; 10(6):371-4. PubMed ID: 6095003
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of phosphate and vitamin D to prevent dwarfism and rickets in X-linked hypophosphatemia.
    Glorieux FH; Scriver CR; Reade TM; Goldman H; Roseborough A
    N Engl J Med; 1972 Sep; 287(10):481-7. PubMed ID: 4340235
    [No Abstract]   [Full Text] [Related]  

  • 10. Growth in children with X-linked hypophosphataemic rickets.
    Verge CF; Cowell CT; Howard NJ; Donaghue KC; Silink M
    Acta Paediatr Suppl; 1993 Mar; 388():70-5; discussion 76. PubMed ID: 8329834
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypophosphatemic rickets: still misdiagnosed and inadequately treated.
    Greene WB; Kahler SG
    South Med J; 1985 Oct; 78(10):1179-84. PubMed ID: 2996152
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acquired hypophosphataemic vitamin D resistant rickets in black children.
    Pettifor JM; Ross FP; Quirk M; Moodley GP; Cavaleros M
    Bone Miner; 1986 Sep; 1(4):307-19. PubMed ID: 2849486
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of GH replacement therapy in two male siblings with combined X-linked hypophosphatemia and partial GH deficiency.
    Schütt SM; Schumacher M; Holterhus PM; Felgenhauer S; Hiort O
    Eur J Endocrinol; 2003 Oct; 149(4):317-21. PubMed ID: 14514346
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Linear growth in relation to the circulating concentrations of insulin-like growth factor I, parathyroid hormone, and 25-hydroxy vitamin D in children with nutritional rickets before and after treatment: endocrine adaptation to vitamin D deficiency.
    Soliman AT; Al Khalaf F; Alhemaidi N; Al Ali M; Al Zyoud M; Yakoot K
    Metabolism; 2008 Jan; 57(1):95-102. PubMed ID: 18078865
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of recombinant human growth hormone in children with X-linked hypophosphatemia.
    Seikaly MG; Brown R; Baum M
    Pediatrics; 1997 Nov; 100(5):879-84. PubMed ID: 9346990
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Hypophosphatemia of a genetic origin].
    Escoubet B; Silve C
    Nephrologie; 1992; 13(3):115-21. PubMed ID: 1641053
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyperparathyroidism in patients with X-linked dominant hypophosphatemic rickets--application of the calcium infusion test as an indicator for parathyroidectomy.
    Alon U; Newsome H; Chan JC
    Int J Pediatr Nephrol; 1984 Mar; 5(1):39-43. PubMed ID: 6609135
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dentin structure in familial hypophosphatemic rickets: benefits of vitamin D and phosphate treatment.
    Chaussain-Miller C; Sinding C; Septier D; Wolikow M; Goldberg M; Garabedian M
    Oral Dis; 2007 Sep; 13(5):482-9. PubMed ID: 17714351
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Growth hormone treatment of familial hypophosphatemic rickets].
    Saggese G; Baroncelli GI; Barsanti S
    Arch Pediatr; 1998; 5 Suppl 4():360S-363S. PubMed ID: 9853084
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.